The Quiet Squeeze in the Money Markets

Below is an important message from one of our valued partners along with today's top headlines "Prepare for Five Years of Famine" - Ad Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: "Prepare for Five Years of Famine". Continue reading... Amazon Faces Regulatory Heat For Anticompetitive Strategies On Third-Party Sellers, Wholesalers California state attorney general prosecuted Amazon.com, Inc (NASDAQ: AMZN) for allegedly inflating prices, stifling competition, and violating the antitrust laws with third-party sellers' and wholesalers' contracts,  Continue reading... Do You Have Plans for Tuesday? Circle September 20th on Your Calendar. - Ad Finding the right crypto -- at the very beginning -- can lead to huge, life-changing gains. And that leads to the big question...How do you find tomorrow's blockbuster cryptos? Is there an easy way to separate the eventual "winners" from the "losers"? Well, that's what I'm here for. Continue reading... As Ethereum Merge Happens, Another Crypto Sees Unexpected 66% Rally: Vitalik Buterin Says 'Celsius' Converted To 'Fahrenheit' The native token of the Celsius Network (CRYPTO: CEL) unexpectedly rallied 66% immediately after the Ethereum (CRYPTO: ETH) Continue reading... Cathie Wood Buys Nearly $7M In This Sapped Bitcoin-Linked Stock -- Also Picks Up Shares In CareDx Cathie Wood-led Ark Investment Management has bought over 100,000 shares of Jack Dorsey's Block Inc (NYSE: SQ), valued at over $6.9 million based on Wednesday's closing price. Continue reading... Apple (AAPL) is making moves behind the scenes to prepare for a downturn... - Ad The man who predicted the 2020 crash and famously called the overnight collapse of Priceline.com on CNBC has been sharing a public warning. Including how to predict which stocks could plummet next, and which could boom in the coming recession. If you have any serious assets in the market, there is one critical step you must take now. Continue reading... Delayed Generic Entry Is Positive For This Large Pharma's HIV Franchise Sales, Analyst Says Gilead Sciences Inc (NASDAQ: GILD) disclosed agreements with generic manufacturers that delay the U.S. launch of generic TAF products from 2025 to 2031/2032.  Continue reading... Founder Of World's Largest Hedge Fund Rails Against Fed, Predicts 20% Stock Plummet The Federal Reserve's raising of interest rates could bring the economy "down," according to billionaire Ray Dalio. In a recent LinkedIn post, the Bridgewater Associates founder said increasing interest rates to about 4.5% -- meant to offset inflation -- will cause stock prices to plummet by 20%. Continue reading... ALERT: Sell These Four Funds Today - Ad If you own funds from Fidelity, iShares, or Franklin Templeton, you may have a ticking time bomb sitting in your portfolio. Read this urgent briefing to see why this could set your retirement back ten years! Continue reading... 'Everything's Down' In 2022 Not Just Crypto, FTX CEO Bankman-Fried Tells Mooch Keading cryptocurrencies are not the only investments that are down in 2022, according to FTX CEO and co-founder Sam Bankman-Fried. "Everything's down this year because dollars are up this year," Bankman-Fried told SkyBridge Capital founder Anthony Scaramucci at the SALT Conference this week. Continue reading... Disney's ESPN, DraftKings And Others Get An Apple App Store Boost From NFL Opening Weekend More than 121 million people viewed at least part of the NFL's opening weekend slate of games, but ratings weren't the only thing getting a boost when the 2022 season officially kicked off. Several mobile applications saw increased usage and download volume over the weekend. Here's what you need to know: Continue reading... 1K Would Be 13M Today. This Is CRAZY - Ad Learn a profitable newbie-friendly crypto loophole that works no matter if markets are up or down. Register for our free "Loophole" strategy training today. Continue reading... Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A. Continue reading... MAPS Gets A New Partner To Study MDMA Therapy In Patients With PTSD In recent months, the psychedelics space has been ground for increasing collaborations. In some cases it was to advance scientific studies. Continue reading... This Top Bargain Energy Stock Has Upside Potential Energy stocks aren't simply limited to oil, gas, and coal...renewable energy, like solar and wind sources, tend to be popular picks too. Here's today's latest bargain energy stock. Continue reading... 3 REITs For Reliable Passive Income You're an investor who's looking at retirement in just a few short years. You want to transition from growth investments to income-producing instruments. You want solid investments you can hang on to for several years, but you're looking for a higher yield than what's available with bank certificates of deposit or U.S. Treasuries. Continue reading... A New Federal Bill Would Help Small Weed Farmers Compete With Big MSOs Rep. Jared Huffman and Rep. Earl Blumenauer filed a bill that would help small cannabis growers compete against multi-state operators when (and if) marijuana is federally legalized. Continue reading... Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma Numinus Updates On New Acquisition's Integration And Provides Client Financing Options Continue reading... The information provided by us is for educational and informational purposes only, and not for individualized investment management. This email contains commercial elements, such as advertising. We send these offers to only those who have opted in to our newsletter. To no longer receive these offers, please click on the unsubscribe link at the bottom of this email. Past performance is not always indicative of future results. Therefore we strongly suggest trading in a DEMO/Simulated account. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault. Copyright © 2022. Musth | SystemTrading - 339-20 De Boers Dr, Toronto, ON M3J 0H1  Unsubscribe Here